Sunday , November 29 2020

Chile will deliver pills to prevent the spread of HIV NEWS | industry

Chile's government announced on Friday free delivery of pre-exposure prophylactic pills (PrEP)a drug that prevents HIV transmission; below first quarter of 2019.

In addition, the authorities in Chile, a country that saw the number of people infected with the virus twice over the last seven years, met with members of Movement of homosexual integration and liberation (Movilh) to define the protocols that govern the use of the next year.

"PrEP pills can reduce the chance of acquiring the virus by more than 90% during sexual practice if taken daily. Therefore, there must be a protocol that directs people about its real effects and encourages them to favor safe sexual practices, as it is not the idea that the pill causes relaxation, "said Movilh Health Area leader Diego Ríos.

According to the Minister of Health, Emilio Santelices, The PrEP pill is part of a new plan against AIDS and HIV, and will be used as a preventive treatment in high-risk populations.

How does it work?

According to the Centers for Disease Control and Prevention of the United States (CDC), if PrEP is taken daily, you get reduce by more than 90% The chances of entering the virus that causes AIDS through six or 70% using needles that are not sterilized or used by multiple people.

PrEP contains emtricitabine and tenofovir, two drugs also used in antiretrovirals because they reduce the amount of virus in the blood and prevent it from multiplying.

The pills do not act as a vaccine as they do not produce antibodies, but rather that their daily intake is necessary so that emtricitabine and tenofovir are present in the blood at the time of infection and prevents HIV from being established in the body.

Before consuming it, it is necessary to verify the good condition of the kidneys and liver, as the birth control pill can cause disruption to these organs.

More information

It was the US pharmaceutical company Gilead Sciences that began marketing this medicine in 2012 under the trademark Truvada. It is estimated that the commercial value of the monthly treatment reaches $ 600.

Years later, the World Health Organization (WHO) began to recommend it to prevent HIV among high-risk groups, such as Sex workers or couples of infected patients.

The data

According to data from Onusida referring to 2017, 67,000 people in Chile are infected with the HIV virus, of whom 39,001 are under treatment, while projections indicate an increase of those affected to 100,000 by the end of this year.

Source link